Increased Risk for Adolescents & Young Adults

Typical adolescent behaviors can promote the transmission of the bacteria that cause meningococcal disease.

Adolescents and young adults are likely to engage in3-5

The numbers behind the threat

Almost 1 in 4

adolescents may be asymptomatic carriers of the bacteria2

 

1 in 10

of those who develop the disease die6

3 in 5

adolescent survivors will experience significant disabilities1

1 in 4

The CDC recommends vaccination against serogroups A, C, Y and W. However, 1 in 4 persons aged 13 to 17 is not vaccinated. Vaccination for serogroup B became available in 20147

 

University outbreaks between 2013 and 2015 in the United States demonstrate the seriousness of meningococcal disease.8,9

Between 2013 and 2015, four colleges in the United States experienced meningococcal meningitis outbreaks.8-11 In 2015 alone, the University of Oregon saw seven cases—one resulting in a student's death.11

Learn more about how campuses are coping with the risk.

 

 

 

Click here to see the incidence on college campuses in your area.

Pfizer’s research is focusing on meningococcal disease in adolescents and young adults.

Register

References: 1.  Borg J, Christie D, Coen PG, et al. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123(3):e502-e509. 2. Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853-861.  3. Tully J, Viner RM, Coen PG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ. 2006;332(7539):445-450. 4. Bruce MG, Rosenstein NE, Capparella JM, et al. Risk factors for meningococcal disease in college students. JAMA. 2001;286(6):688-693. 5. Mayo Clinic Staff. Diseases and conditions: meningitis. Mayo Clinic website http://www.mayoclinic.org/diseases-conditions/meningitis/basics/prevention/con-20019713?p=1. Accessed September 19, 2014. 6. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report. Emerging Infections Program Network. Neisseria meningitidis, 2012. 7. Data on file. Innovation advisory board pre-reading. Part 1: general background—adolescent health and vaccination. November 2013. Pfizer Inc, New York, NY. 8. Princeton University meningococcal disease outbreak. Centers for Disease Control and Prevention website. http://www.cdc.gov/meningococcal/outbreaks/ princeton.html. Accessed July 8, 2014. 9. University of California, Santa Barbara meningococcal disease outbreak. Centers for Disease Control and Prevention website. http://www.cdc.gov/meningococcal/outbreaks/ucsb.html. Accessed July 8, 2014. 10. Soeters HM, McNamara LA, Whaley M, et al. Serogroup B meningococcal disease outbreak and carriage evaluation at a college—Rhode Island, 2015. MMWR. 2015;64(22):606-607. 11. Hammond B. University of Oregon meningitis vaccination will be largest in US since approval of new drug. The Oregonian/OregonLive. Updated February 27, 2015. http://www.oregonlive.com/education/index.ssf/2015/02/university_ of_oregon_meningiti.html. Accessed October 13, 2016.